Efficacy and safety of palbociclib and ribociclib in patients with estrogen and/or progesterone receptor positive, HER2 receptor negative metastatic breast cancer in routine clinical practice.
<h4>Background</h4>There is scant data from India on efficacy and safety of palbociclib and ribociclib in routine clinical practice.<h4>Methods</h4>This retrospective, observational, single institution study included patients with estrogen and/or progesterone receptor positiv...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/4e01cb73ac5f4ba695434e6fa2625692 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|